This is the authors' abstract. We don't add key points for this paper.
Dengue virus (DENV) infection causes diseases ranging from dengue fever to life-threatening dengue hemorrhagic fever and dengue shock syndrome characterized by endothelial dysfunction, vascular leakage, and shock. Here, we reveal a distinct mechanism by which DENV induces tissue injury and vascular leakage through promoting interleukin-1β (IL-1β) activation. DENV facilitates IL-1β secretion in infected patients, mice, human peripheral blood mononuclear cells (PBMCs), mice bone marrow-derived macrophages (BMDMs), and monocyte-differentiated macrophages (THP-1) via activating the NLRP3 inflammasome. Moreover, IL-1β induces vascular leakage and tissue injury in interferon alpha/beta receptor 1 deficient C57BL/6 mice (IFNAR-/- C57BL/6), whereas interleukin-1 receptor antagonist (IL-1RA) inhibits IL-1β-induced vascular leakage and tissue injury in mice. Finally, recombinant IL-1β protein can induce directly vascular leakage and tissue injury in C57BL/6 mice. Therefore, this study demonstrates a major contribution of IL-1β to DENV-associated pathology, and suggests IL-1RA acting as a potential agent for the infectious diseases.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: